In the fiercely competitive inflammatory bowel disease (IBD) market, Eli Lilly is making the case for its antibody Omvoh as a ...

Advocacy, too, is a priority, and the organization hosts special events such as a Day on the Hill and Crohn's and Colitis ...

Success rates much higher with embryo transfer versus intrauterine insemination ...

The environment is a critical factor in the development of inflammatory bowel disease (IBD). In this Perspective, the authors summarize the latest evidence on the exposome and IBD risk, encompassing ...

Eli Lilly (NYSE: LLY) reported new clinical analyses showing its Omvoh therapy achieved corticosteroid free disease control ...

Assisted reproductive technology, particularly IVF, appears to be effective for women with inflammatory bowel disease, ...

Individual food compounds, rather than broad food groups, may have important effects on IBD disease activity. A machine learning model identified food compounds associated with modulating disease ...

From joint pain to skin changes, your body can experience the condition in ways you might not expect.

Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a novel composite outcome defined by ...

Early onset IBD activity correlates with higher psychiatric diagnoses and psychotropic medication use. Active IBD patients have increased odds of developing major depressive disorder, anxiety, and ...

Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. World revenue for the Inflammatory ...

Researchers found that late-night eating -- after dinner or bedtime -- was associated with a 28% increased risk for liver cirrhosis and a 36% higher risk for metabolic dysfunction-associated steatotic ...